Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease
- PMID: 19798558
- DOI: 10.1007/s10863-009-9243-5
Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease
Abstract
Beta-amyloid (Abeta) deposition, in the form of plaques and amyloid angiopathy, and hyper-phosphorylated tau deposition forming neurofibrillary tangles, dystrophic neurites around beta-amyloid plaques and neuropil threads, are neuropathological hallmarks of Alzheimer's disease (AD) that accumulate in the brain with disease progression. These changes are accompanied by progressive loss of synapses and nerve cell death. Progressive cognitive impairment and dementia are the main neurological deficits. In addition, there is cumulative evidence demonstrating other metabolic disturbances that impair cell function and hamper neuron viability. The main components of the mitochondria are altered: complex IV of the respiratory chain is reduced; complex V which metabolizes ADP to form ATP is oxidatively damaged and functionally altered; and voltage-dependent anion channel VDAC, a major component of the outer mitochondrial membrane that regulates ion fluxes, is damaged as a result of oxidative stress. Mitochondria are a major source of reactive oxygen species that promote oxidative damage to DNA, RNA, proteins and lipids. Protein targets of oxidative damage are, among others, several enzymatic components of the glycolysis, lipid metabolism and cycle of the citric acid that fuel oxidative phosphorylation, mitochondrial respiration and energy production. The lipid composition of lipid rafts, key membrane specializations that facilitate the transfer of substrates, and protein-protein and lipid-protein interactions, is altered as a result of the abnormally low levels of n-3 long chain polyunsaturated fatty acids (mainly docosahexaenoic acid) that increase viscosity and augment energy consumption. Abnormal lipid raft composition may also modify the activity of key enzymes that modulate the cleavage of the amyloid precursor protein to form toxic Abeta. This is further complicated by the disruption of the complex VDAC with estrogen receptor alpha at the caveolae which participates, under physiological conditions, in the protection against beta-amyloid. Together, all these alterations converge in reduced energy production and increased energy demands in altered cells. Cell exhaustion is suggested as being a determining element to interpret impaired neuron function, reduced molecular turnover, and enhanced cell death.
Similar articles
-
Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.Neuroscience. 2014 Oct 10;278:354-66. doi: 10.1016/j.neuroscience.2014.07.079. Epub 2014 Aug 26. Neuroscience. 2014. PMID: 25168729
-
VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease.Mol Cell Neurosci. 2009 Nov;42(3):172-83. doi: 10.1016/j.mcn.2009.07.001. Epub 2009 Jul 10. Mol Cell Neurosci. 2009. PMID: 19595769
-
Dysfunction of Mitochondria in Alzheimer's Disease: ANT and VDAC Interact with Toxic Proteins and Aid to Determine the Fate of Brain Cells.Int J Mol Sci. 2022 Jul 13;23(14):7722. doi: 10.3390/ijms23147722. Int J Mol Sci. 2022. PMID: 35887070 Free PMC article. Review.
-
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.Neurol Res. 2003 Sep;25(6):665-74. doi: 10.1179/016164103101201977. Neurol Res. 2003. PMID: 14503022
-
New findings concerning vertebrate porin II--on the relevance of glycine motifs of type-1 VDAC.Mol Genet Metab. 2013 Apr;108(4):212-24. doi: 10.1016/j.ymgme.2013.01.008. Epub 2013 Jan 26. Mol Genet Metab. 2013. PMID: 23419876 Review.
Cited by
-
Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation.Oxid Med Cell Longev. 2015;2015:346783. doi: 10.1155/2015/346783. Epub 2015 May 24. Oxid Med Cell Longev. 2015. PMID: 26090071 Free PMC article. Review.
-
The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.J Immunol Res. 2018 Aug 12;2018:4892473. doi: 10.1155/2018/4892473. eCollection 2018. J Immunol Res. 2018. PMID: 30159340 Free PMC article. Review.
-
Up-regulation of Synaptotagmin IV within amyloid plaque-associated dystrophic neurons in Tg2576 mouse model of Alzheimer's disease.Croat Med J. 2013 Oct 28;54(5):419-28. doi: 10.3325/cmj.2013.54.419. Croat Med J. 2013. PMID: 24170720 Free PMC article.
-
Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.Antioxid Redox Signal. 2011 Oct 15;15(8):2095-107. doi: 10.1089/ars.2010.3877. Epub 2011 Jun 8. Antioxid Redox Signal. 2011. PMID: 21453200 Free PMC article.
-
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Front Pharmacol. 2014 Mar 5;5:37. doi: 10.3389/fphar.2014.00037. eCollection 2014. Front Pharmacol. 2014. PMID: 24634659 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical